Literature DB >> 11470020

Tailoring Antibiotic Treatment to Host Immune Status: The Host, Not the Drug, Determines Outcome.

Peter J. McDonald1, Hendrik Pruul.   

Abstract

Year:  2001        PMID： 11470020     DOI： 10.1007/s11908-001-0065-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  8 in total

1.  The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Ann Intern Med       Date:  1950-09       Impact factor: 25.391

Review 2.  Phagocyte uptake and transport of azithromycin.

Authors:  P J McDonald; H Pruul
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

3.  Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Authors:  S G Deeks; T Wrin; T Liegler; R Hoh; M Hayden; J D Barbour; N S Hellmann; C J Petropoulos; J M McCune; M K Hellerstein; R M Grant
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

4.  High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes.

Authors:  H Koga
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 5.  Macrolides and the immune system.

Authors:  P J McDonald; H Pruul
Journal:  Scand J Infect Dis Suppl       Date:  1992

6.  Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.

Authors:  H Pruul; P J McDonald
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood.

Authors:  M J Schultz; P Speelman; S Zaat; S J van Deventer; T van der Poll
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

8.  Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis.

Authors:  M H Lebel; M J Hoyt; G H McCracken
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.